Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Up 1,102.1% in December

Polyrizon Ltd. (NASDAQ:PLRZ) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 176,028 shares, an increase of 1,102.1% from the November 30th total of 14,643 shares. Currently, 16.9% of the shares of the company are short sold. Based on an average daily volume of 16,817,222 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 16,817,222 shares, the days-to-cover ratio is currently 0.0 days. Currently, 16.9% of the shares of the company are short sold.

Polyrizon Trading Up 5.3%

Shares of NASDAQ PLRZ traded up $0.38 during midday trading on Wednesday, hitting $7.61. The company’s stock had a trading volume of 58,391 shares, compared to its average volume of 9,582,408. The firm’s fifty day moving average price is $6.92 and its 200-day moving average price is $6.41. Polyrizon has a 1-year low of $2.88 and a 1-year high of $4,200.00.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PLRZ. Wall Street Zen raised shares of Polyrizon from a “strong sell” rating to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Polyrizon in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Polyrizon has an average rating of “Sell”.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.